Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Zifo Unveils AI-Driven Scientific Semantic Layer Vision for Biopharma

Zifo Logo

News provided by

Zifo

Sep 28, 2026, 09:00 ET

Share this article

Share toX

Share this article

Share toX

New framework aims to turn fragmented scientific data into trusted, evidence-backed intelligence for enterprise AI.

Next generation of scientific AI will require more than access to large volumes of data.

CAMBRIDGE, Mass. and CAMBRIDGE, England, Sept. 28, 2026 /PRNewswire/ -- Zifo, a global enabler of AI and data-driven enterprise informatics for science-driven organizations, today unveiled its vision for an AI-driven scientific semantic layer, a dynamic framework designed to help Biopharma companies build a more trusted foundation for enterprise AI.

AI is rapidly becoming part of scientific discovery. But the quality of its output still depends on the quality, context, and meaning of the data it receives.

Continue Reading
Zifo’s proposed framework reimagines the semantic layer as something more fundamental: a living scientific intelligence asset that can evolve alongside science.
Zifo’s proposed framework reimagines the semantic layer as something more fundamental: a living scientific intelligence asset that can evolve alongside science.

That is a significant challenge in life sciences, where data is distributed across electronic laboratory notebooks (ELNs), laboratory information management systems (LIMS), clinical platforms, manufacturing environments, regulatory repositories, and specialized scientific applications. Each system may describe the same scientific concept differently. Even within a single organization, terminology, structures, units, and interpretations can vary from one team or domain to another.

Traditional semantic layers were largely created to make data easier to query and report. They rely on predefined models, manual mappings, and ongoing curation. That approach can support business intelligence, but it often struggles to keep pace with the speed at which scientific knowledge, data volumes, and industry standards are changing.

"The next generation of scientific AI will require more than access to large volumes of data," said Aishwarya Balajee, who leads the Scientific Data Foundation and FAIR Data Factory practice at Zifo. "It will need to understand what that data means, where it came from, what evidence supports it, and how scientific interpretation has changed over time. A governed scientific semantic layer brings that context together."

From Static Data Models to Evolving Scientific Context

A central principle of the framework is the separation of scientific identity from scientific interpretation.

Core entities such as compounds, biological targets, biomarkers, assays, samples, studies, genes, proteins, and clinical trials can remain persistent throughout the research and development lifecycle. What scientists understand about those entities, however, may change as new evidence emerges.

A compound, for example, remains the same compound even as researchers uncover new information about its mechanism, therapeutic relevance, toxicity, or potential use in another disease area. The identity remains stable. The scientific interpretation evolves.

By separating the two, organizations can incorporate new knowledge without losing historical context. Semantic relationships, confidence scores, ontology mappings, and scientific assertions can be updated over time, while each change remains connected to its evidence, provenance, approval status, and version history.

The result is a semantic layer that captures not only what an organization knows, but also why it believes it, who approved it, and when that understanding changed.

AI Recommends. Scientists Govern.

The proposed architecture uses specialized AI agents built by Zifo to support different parts of the semantic-management lifecycle.

These agents can read scientific documents and datasets, identify concepts and relationships, align terminology with enterprise ontologies and public standards, propose mappings, detect unit conflicts, flag inconsistencies, and monitor changes to external standards.

Rather than simply presenting a suggested answer, the system is designed to package the evidence behind its recommendation. Scientists and data stewards can then accept, modify, or reject it.

Those decisions become part of a continuous learning loop.

When a steward approves a mapping, the system learns from that decision. When the same mapping is successfully reused across studies or improves downstream data quality, the pattern becomes more valuable. When a recommendation is rejected, or leads to an issue, the system uses that outcome to recalibrate similar suggestions.

The aim is not to remove scientific experts from the process. It is to remove repetitive work around them.

"This is not about asking AI to make scientific decisions," said Ragavi Shanmugam, Zifo's Lead for Scientific Data Architecture, who drives Data Solutions for Translational, Cell & Gene Therapy, & Biomarker Discovery. "AI can process information at scale, surface likely relationships, and identify areas of uncertainty. Scientists remain responsible for the decisions that drives key business outcomes and can use AI to accelerate the process."

Under the model, AI can read, analyze, extract, compare, recommend, and learn. It cannot independently alter approved mappings, introduce concepts into an enterprise ontology, or change governance policies.

That distinction is especially important in regulated scientific environments, where semantic decisions may affect downstream research, manufacturing, clinical, or regulatory processes.

Building a Foundation for Trustworthy Enterprise AI

A governed scientific semantic layer can provide the contextual foundation needed by large language models (LLMs), copilots, knowledge-discovery tools, and other enterprise AI applications.

Instead of reasoning directly over fragmented raw data, AI systems can work with semantically enriched concepts, knowledge graphs, ontologies, and linked evidence. This can improve scientific retrieval, strengthen traceability, and make AI-generated responses easier to validate.

The framework is intended to help Biopharma organizations:

  • Preserve scientific knowledge as organizational memory.
  • Reuse approved semantic mappings across projects, systems, and scientific domains.
  • Accelerate the onboarding of instruments, CRO datasets, and new applications.
  • Reduce manual work associated with terminology alignment and unit conversion. Identify the downstream effects of changing standards earlier.
  • Maintain evidence, lineage, confidence, and approval history for scientific assertions.
  • Ground enterprise AI in governed, evidence-backed scientific context.

The approach is also built on FAIR data principles, which help make scientific data findable, accessible, interoperable, and reusable. A strong FAIR foundation allows the semantic layer to focus less on resolving duplicate concepts and terminology conflicts, and more on relationship discovery and scientific reasoning.

Starting Small, Then Scaling

Zifo recommends an incremental path to adoption.

Organizations can begin with one focused scientific domain, a small number of source systems, and a complete workflow from AI-generated recommendation to expert review and feedback capture. This provides an opportunity to demonstrate value, calibrate confidence levels, and establish governance before expanding further.

As the system learns from approved mappings and expert corrections, routine cases can be handled more efficiently. Scientists and stewards can then focus their time on the novel, ambiguous, and high-impact decisions where their expertise matters most.

Over time, the semantic layer can expand into adjacent domains and ultimately create shared scientific meaning across the enterprise.

About Zifo

Zifo is a global enabler of AI and data-driven enterprise informatics for science-driven organizations. With solutions and services expertise spanning research, development, manufacturing, and clinical domains, Zifo supports organizations across the pharmaceutical, biotechnology, chemicals, food and beverage, oil and gas, and fast-moving consumer goods industries.

Trusted by more than 190 science-focused organizations worldwide, Zifo helps enterprises advance digital scientific innovation and establish connected, data-driven scientific environments. For more information, visit https://zifo.com; https://zifo.com/practical-ai-blueprints/

SOURCE Zifo

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Zifo's AI-Powered Clinical Reporting Solution Named Runner-Up in the 2026 CDISC AI Innovation Challenge

Zifo's AI-Powered Clinical Reporting Solution Named Runner-Up in the 2026 CDISC AI Innovation Challenge

Zifo, a leading global enabler of AI and data-driven enterprise informatics for science-driven organizations, has been named runner-up in the 2026...

Zifo Survey: Biopharma Eyes ROI and Lab Orchestration as Agentic AI Takes Shape

Zifo Survey: Biopharma Eyes ROI and Lab Orchestration as Agentic AI Takes Shape

Last year, the biopharma industry was asking whether its data was ready for AI. This year, the question has changed. Is the scientific enterprise...

More Releases From This Source

Explore

Data Analytics

Data Analytics

Data Analytics

Data Analytics

The Latest Artificial Intelligence News

The Latest Artificial Intelligence News

Artificial Intelligence

Artificial Intelligence

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.